Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received an average rating of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company.

Several equities analysts recently issued reports on SAUHY shares. Barclays reissued an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Citigroup reiterated a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. BMO Capital Markets assumed coverage on Straumann in a report on Wednesday, July 8th. They issued an “outperform” rating on the stock. Deutsche Bank Aktiengesellschaft lowered Straumann from a “buy” rating to a “hold” rating in a research report on Friday, August 21st. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th.

Straumann Stock Performance

Shares of SAUHY opened at $11.55 on Tuesday. The company has a 50-day moving average price of $12.45 and a two-hundred day moving average price of $11.66. Straumann has a 12 month low of $9.44 and a 12 month high of $13.61.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.